๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

An X-linked lymphoproliferative disease (XLP) patient with uneventful primary infection and fatal reactivation with Epstein-Barr virus (EBV)

โœ Scribed by H. Moriuchi; T. Kondo; Y. Fukuda; H. Kanegane; H. Kimura; K. Kuzushima


Book ID
118616227
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
144 KB
Volume
6
Category
Article
ISSN
1201-9712

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Differential cellular susceptibility to
โœ Motohiko Okano; Geoffrey M. Thiele; Thomas G. Gross; Jack R. Davis; David T. Pur ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 925 KB

## Abstract Epsteinโ€Barr virus (EBV) is often associated with lethal lymphoproliferative disease in immunologically compromised individuals. Recently, we have studied a 20โ€monthโ€old boy with Xโ€linked lymphoproliferative disease (XLP) who had succumbed to infectious mononucleosis (IM) complicated by

Quantitative Epstein-Barr virus (EBV) se
โœ Erik Verschuuren; Wim van der Bij; Wim de Boer; Wim Timens; Jaap Middeldorp; T. ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB ๐Ÿ‘ 1 views

## Abstract The Epsteinโ€Barr virus (EBV)โ€specific antibody response was studied in lung transplant patients to assess their value in the diagnosis and prognosis of postโ€transplant lymphoproliferative disease. Recently developed synthetic peptides representing Epsteinโ€Barr nuclear antigenโ€1 (EBNAโ€1)